LENZ Therapeutics, Inc. Ratios

Ratios Dec2020 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 33,850.00%
EBIT Margin 33,750.00%
EBITDA Margin 33,750.00%
Operating Margin 33,750.00%
Net Margin 33,850.00%
FCF Margin 25,665.00%-630.49%
Efficiency
Invested Capital 296.29M
Leverage & Solvency
Interest Coverage Ratio -337.50
Equity Ratio 0.92
Times Interest Earned -337.50
Valuation
Enterprise Value -75.16M151.95M793.95M
Market Capitalization 193.07M151.95M793.95M
Return Ratios
Return on Sales 338.50%